Oestradiol-progesterone combo cleared of abnormal mammogram risk
Treatment with the oral combination of 17β-oestradiol and progesterone in postmenopausal women does not appear to be related to abnormal mammograms, and the incidence of breast tenderness is low as compared with the rates reported in other hormone therapy studies, according to data from the phase III trial REPLENISH.
